PHARMACOLOG I UPPSALA B
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. The company offers DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the tes… Read more
Market Cap & Net Worth: PHARMACOLOG I UPPSALA B (P750)
PHARMACOLOG I UPPSALA B (F:P750) has a market capitalization of $48.68 Million (€47.42 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #34823 globally and #4041 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PHARMACOLOG I UPPSALA B's stock price €0.44 by its total outstanding shares 108520000 (108.52 Million).
PHARMACOLOG I UPPSALA B Market Cap History: 2020 to 2026
PHARMACOLOG I UPPSALA B's market capitalization history from 2020 to 2026. Data shows change from $1.15 Billion to $48.68 Million (-44.50% CAGR).
PHARMACOLOG I UPPSALA B Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PHARMACOLOG I UPPSALA B's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of P750 by Market Capitalization
Companies near PHARMACOLOG I UPPSALA B in the global market cap rankings as of March 18, 2026.
Key companies related to PHARMACOLOG I UPPSALA B by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
PHARMACOLOG I UPPSALA B Historical Marketcap From 2020 to 2026
Between 2020 and today, PHARMACOLOG I UPPSALA B's market cap moved from $1.15 Billion to $ 48.68 Million, with a yearly change of -44.50%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €48.68 Million | -17.55% |
| 2025 | €59.04 Million | +32.50% |
| 2024 | €44.56 Million | +455.56% |
| 2023 | €8.02 Million | -98.51% |
| 2022 | €540.03 Million | -76.83% |
| 2021 | €2.33 Billion | +103.15% |
| 2020 | €1.15 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of PHARMACOLOG I UPPSALA B was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $48.68 Million USD |
| MoneyControl | $48.68 Million USD |
| MarketWatch | $48.68 Million USD |
| marketcap.company | $48.68 Million USD |
| Reuters | $48.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.